These results have important implications for emerging considerations regarding outcomes of low- or high-salt (Western) diet in the context of autoimmune diseases such as MS (61), as well as for future therapies to block GM-CSF in MS patients, which is already in a phase I clinical trial (62). The gene discussed is CSF2; the disease is autoimmune disease.